Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
22.8K
-
Shares change
-
-45.3K
-
Total reported value, excl. options
-
$211K
-
Value change
-
-$459K
-
Number of sells
-
-1
-
Price
-
$9.26
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q4 2023
2 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q4 2023.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.8K shares
of 69.1M outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.51M shares), BlackRock Inc. (5.32M shares), Point72 Asset Management, L.P. (4.16M shares), WELLINGTON MANAGEMENT GROUP LLP (3.14M shares), Daventry Group, LP (1.92M shares), Impax Asset Management Group plc (1.75M shares), DIMENSIONAL FUND ADVISORS LP (1.55M shares), PRIMECAP MANAGEMENT CO/CA/ (1.42M shares), STATE STREET CORP (1.29M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.26M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.